Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
申请人:——
公开号:US20020013297A1
公开(公告)日:2002-01-31
The present invention describes novel halogenated triphenylethylene derivatives, or pharmaceutically acceptable prodrug or salt forms thereof, as selective estrogen receptor modulators for the treatment of and/or prevention of breast, uterine, ovarian, prostrate and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders, as well as methods for making the compounds and pharmaceutical compositions of this invention.
本发明描述了新型卤代三苯乙烯衍生物,或其药学上可接受的前药或盐形式,作为选择性雌激素受体调节剂,用于治疗和/或预防乳腺、子宫、卵巢、前列腺和结肠癌、骨质疏松症、心血管疾病和良性增生性疾病,以及制备这些化合物的方法和本发明的药物组合物。